Linked Data API

Show Search Form

Search Results

922426
star this property registered interest false more like this
star this property date less than 2018-06-12more like thismore than 2018-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Department of Health and Social Care: Re-employment more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text Can the Secretary of State for Health and Social Care, how many staff made redundant by his Department between January and March 2017 have been reemployed by his Department on (a) permanent, (b) agency or (c) contractor contracts. more like this
star this property tabling member constituency Leeds North West more like this
star this property tabling member printed
Alex Sobel more like this
unstar this property uin 152853 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-06-20more like thismore than 2018-06-20
star this property answer text <p>No staff have been reemployed by the Department who previously left under compulsory or voluntary redundancy, between January and March 2017.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2018-06-20T11:09:19.497Zmore like thismore than 2018-06-20T11:09:19.497Z
unstar this property answering member
4008
star this property label Biography information for Dame Caroline Dinenage more like this
star this property tabling member
4658
star this property label Biography information for Alex Sobel more like this
988456
star this property registered interest false more like this
star this property date less than 2018-10-15more like thismore than 2018-10-15
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Mental Illness: Prescription Drugs more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government (1) how many community prescriptions for mental health conditions were paid for by patients via prescription charges, and (2) what was the percentage of prescriptions for mental health conditions of overall community prescriptions in (a) 2015, (b) 2016, and (c) 2017. more like this
star this property tabling member printed
Baroness Jolly more like this
unstar this property uin HL10655 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-10-29more like thismore than 2018-10-29
star this property answer text <p>We do not hold this data. Prescription forms do not include a clinical indication, therefore it is not possible to identify prescription items dispensed to treat mental health conditions.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN HL10730 more like this
star this property question first answered
less than 2018-10-29T15:16:18.83Zmore like thismore than 2018-10-29T15:16:18.83Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4203
star this property label Biography information for Baroness Jolly more like this
993365
star this property registered interest false more like this
star this property date less than 2018-10-22more like thismore than 2018-10-22
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Haematological Cancer: Drugs more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government (1) how many drugs were available on the NHS for the treatment of blood cancer, and (2) how much the NHS spent on blood cancer drugs, in each of the past five years. more like this
star this property tabling member printed
Lord Mendelsohn more like this
unstar this property uin HL10893 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-11-05more like thismore than 2018-11-05
star this property answer text <p>NHS England has advised that it is not possible to provide a comprehensive list of drugs that are available specifically for blood cancer or how much the National Health Service spends on blood cancer drugs as cancer drugs are often licenced for multiple different types of cancer.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-11-05T14:29:39.827Zmore like thismore than 2018-11-05T14:29:39.827Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4286
star this property label Biography information for Lord Mendelsohn more like this
885940
star this property registered interest false more like this
star this property date less than 2018-04-17more like thismore than 2018-04-17
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Contraceptives more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government (1) how many, and (2) what percentage of, GPs in England opt out of providing contraceptive services to their registered patients. more like this
star this property tabling member printed
Baroness Tonge more like this
unstar this property uin HL7025 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-05-01more like thismore than 2018-05-01
star this property answer text <p>As at 31 March 2018, there were three practices (0.04%) that had opted out of providing contraceptive services.</p><p> </p><p>The current general practitioner contract allows practices to opt out of providing contraceptive services to their registered patients. Where they do so, NHS England has responsibility for ensuring patients of those practices have access to such services.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-05-01T11:45:49.65Zmore like thismore than 2018-05-01T11:45:49.65Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
200
star this property label Biography information for Baroness Tonge more like this
922991
star this property registered interest false more like this
star this property date less than 2018-06-12more like thismore than 2018-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Leukaemia: Ibrutinib more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government (1) what evidence NHS England considered, (2) which clinicians it consulted, and (3) which patient groups it consulted when deciding that ibrutinib should not be prescribed to people with chronic lymphocytic leukaemia who have been in remission for more than three years. more like this
star this property tabling member printed
Lord Mendelsohn more like this
unstar this property uin HL8564 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-06-26more like thismore than 2018-06-26
star this property answer text <p>NHS England has advised that it develops treatment criteria for cancer and other high cost drugs to support implementation of National Institute for Health and Care Excellence (NICE) guidance and to ensure approved treatments are available as intended, with access funded consistently across the country. These criteria are developed by relevant expert clinical advisers, drawn from NHS England’s 42 Clinical Reference Groups (CRGs). These CRGs have been established to support clinical commissioning across the entire specialised commissioning portfolio.</p><p>In the case of NICE Technology Appraisal TA429 for ibrutinib in previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation, NICE issued the following statement on 8 June 2018:</p><p><strong> </strong>“Given the evidence that was considered by the NICE appraisal committee, we consider it reasonable for the guidance to be read as referring to those patients considered unsuitable for retreatment. Because unsuitability for retreatment is not defined in the guidance, we consider it appropriate for NHS England, as the commissioner, to take clinical advice in order to do so.”</p><p>NHS England took clinical advice in setting the specific treatment criteria linked to this appraisal and we are advised that the criteria were derived from the main study that had underpinned the NICE guidance and are consistent with guidance issued by the European Society for Medical Oncology last updated in June 2017. Between January 2017 and May 2018, nearly 1,000 patients were registered to receive treatment with ibrutinib in this indication. This is in line with NICE’s estimates that 700 adults per year would be eligible for treatment as a result of its guidance.</p><p>However, NHS England has further advised that it is more than willing to receive and review by the end of July, any further evidence that patients and clinicians wish to submit on this matter. The evidence will first be considered by NHS England’s Chemotherapy CRG, with advice and recommendations from this group then being submitted to the National Medical Director, Professor Steve Powis, for consideration.</p><p>During 2017/18, 1,193 Individual Funding Requests were considered by NHS England. An analysis of how may related to treatments for blood cancer has not been conducted.</p><p> </p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN
HL8561 more like this
HL8562 more like this
HL8563 more like this
star this property question first answered
less than 2018-06-26T12:13:53.757Zmore like thismore than 2018-06-26T12:13:53.757Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4286
star this property label Biography information for Lord Mendelsohn more like this
923166
star this property registered interest false more like this
star this property date less than 2018-06-13more like thismore than 2018-06-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Dental Services more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government by what mechanism units of dental activity are distributed to dental practitioners. more like this
star this property tabling member printed
Lord Storey more like this
unstar this property uin HL8630 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-06-27more like thismore than 2018-06-27
star this property answer text <p>Dental contracts and agreements are agreed with dental contract holders by NHS England. Contracts are held by the part of NHS England (the area team) responsible for that region. Each contract has a set value and agreed level of dental activity to be delivered for that value per year. Activity is measured in metrics known as units of dental activity.</p><p> </p><p>Contracts are let by tender under public procurement regulations. The current system was established in 2006. Where a contract existed prior to 2006, it was transferred into the new system and values set under a national formula used to transfer all then existing contracts from the pre-2006 system to the current system.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-06-27T14:13:38.69Zmore like thismore than 2018-06-27T14:13:38.69Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4238
star this property label Biography information for Lord Storey more like this
968791
star this property registered interest false more like this
star this property date less than 2018-09-05more like thismore than 2018-09-05
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Medical Records: Data Protection more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government by what single mechanism a family may exercise their right to dissent from data being used for purposes beyond direct care following the planned removal of the GP "type-2" extract process in October. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
unstar this property uin HL10075 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-09-19more like thismore than 2018-09-19
star this property answer text <p>National data opt-outs are set on an individual basis. Currently patients who wish to set a national data opt-out can do so themselves using the digital, telephone or non-digital (postal) service. The current mechanism for anyone under the age of 13 to opt out of their confidential patient information being shared for purposes beyond the patient’s individual care is through the non-digital route and can only be set by someone with parental responsibility.</p><p>The National Data Opt-out Programme is currently implementing improvements to the existing process for parental opt-outs which will introduce a multi-children version enabling a parent to opt-out more than one child at a time.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-09-19T14:55:17.527Zmore like thismore than 2018-09-19T14:55:17.527Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath more like this
887313
star this property registered interest false more like this
star this property date less than 2018-04-19more like thismore than 2018-04-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Medical Records: Data Protection more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government from when a national data opt-out expressed directly to NHS Digital will apply to data shared for secondary uses by a GP practice and be visible to GP practices. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
unstar this property uin HL7110 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-05-03more like thismore than 2018-05-03
star this property answer text <p>In line with the implementation plan set out in the Government response to the National Data Guardian’s Review of Data Security, Consent and Opt-Outs, <em>Your Data: Better Security, Better Choice, Better Care</em>, general practitioner (GP) practices will be required to apply national data opt-outs, expressed to NHS Digital, by March 2020. By this date national data opt-outs must be applied by all health and care organisations in line with the national data opt-out policy when confidential patient information is being shared for purposes beyond the patient’s individual care (also referred to as secondary uses). NHS Digital has commissioned the GP system suppliers to develop solutions for their GP systems which will enable GP practices to uphold national data opt-outs. We will publish further details as these solutions become available.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-05-03T10:58:31.547Zmore like thismore than 2018-05-03T10:58:31.547Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath more like this
922989
star this property registered interest false more like this
star this property date less than 2018-06-12more like thismore than 2018-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how NHS England formulates approval criteria for drugs already approved by the National Institute for Health and Clinical Excellence; and how it involves (1) patients, and (2) clinicians in this process. more like this
star this property tabling member printed
Lord Mendelsohn more like this
unstar this property uin HL8562 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-06-26more like thismore than 2018-06-26
star this property answer text <p>NHS England has advised that it develops treatment criteria for cancer and other high cost drugs to support implementation of National Institute for Health and Care Excellence (NICE) guidance and to ensure approved treatments are available as intended, with access funded consistently across the country. These criteria are developed by relevant expert clinical advisers, drawn from NHS England’s 42 Clinical Reference Groups (CRGs). These CRGs have been established to support clinical commissioning across the entire specialised commissioning portfolio.</p><p>In the case of NICE Technology Appraisal TA429 for ibrutinib in previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation, NICE issued the following statement on 8 June 2018:</p><p><strong> </strong>“Given the evidence that was considered by the NICE appraisal committee, we consider it reasonable for the guidance to be read as referring to those patients considered unsuitable for retreatment. Because unsuitability for retreatment is not defined in the guidance, we consider it appropriate for NHS England, as the commissioner, to take clinical advice in order to do so.”</p><p>NHS England took clinical advice in setting the specific treatment criteria linked to this appraisal and we are advised that the criteria were derived from the main study that had underpinned the NICE guidance and are consistent with guidance issued by the European Society for Medical Oncology last updated in June 2017. Between January 2017 and May 2018, nearly 1,000 patients were registered to receive treatment with ibrutinib in this indication. This is in line with NICE’s estimates that 700 adults per year would be eligible for treatment as a result of its guidance.</p><p>However, NHS England has further advised that it is more than willing to receive and review by the end of July, any further evidence that patients and clinicians wish to submit on this matter. The evidence will first be considered by NHS England’s Chemotherapy CRG, with advice and recommendations from this group then being submitted to the National Medical Director, Professor Steve Powis, for consideration.</p><p>During 2017/18, 1,193 Individual Funding Requests were considered by NHS England. An analysis of how may related to treatments for blood cancer has not been conducted.</p><p> </p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN
HL8561 more like this
HL8563 more like this
HL8564 more like this
star this property question first answered
less than 2018-06-26T12:13:53.617Zmore like thismore than 2018-06-26T12:13:53.617Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4286
star this property label Biography information for Lord Mendelsohn more like this
845460
star this property registered interest false more like this
star this property date less than 2018-02-20more like thismore than 2018-02-20
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Drugs: Rehabilitation more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government how NHS-led Sustainability and Transformation Plans, including accountable care systems of integrated health and social care, will work with local authority procured substance misuse services to ensure vulnerable service users are given the right priority of access to treatment and care. more like this
star this property tabling member printed
Lord Patel of Bradford more like this
unstar this property uin HL5660 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-03-05more like thismore than 2018-03-05
star this property answer text <p>The Government is clear that decisions about service provision are best taken at a local level by local clinicians.</p><p>Sustainability and transformation partnerships (STPs) are five-year collaborations between the National Health Service, local government and other key partners for improving health and wellbeing, developing new models of care, and improving the quality and efficiency of services in local areas across England.</p><p>The way STPs work in practice will vary according to the needs of different parts of the country and any decision on how they will work with local substance misuse services will be taken at a local level.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-03-05T17:40:25.29Zmore like thismore than 2018-03-05T17:40:25.29Z
unstar this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
3798
star this property label Biography information for Lord Patel of Bradford more like this